New CAR T-Cell therapy offers hope for Tough-to-Treat lymphoma
Disease control
Recruiting now
This trial tests a new treatment called WZTL-002 for people with large B-cell lymphoma that has come back or not responded to standard chemotherapy. The treatment uses a patient's own immune cells, which are modified in a lab to better fight the cancer. The study will check how w…
Phase: PHASE2 • Sponsor: Malaghan Institute of Medical Research • Aim: Disease control
Last updated Apr 29, 2026 02:37 UTC